2 results
Approved WMOPending
To assess the effectivity and safety of 1.0 molar gadobutrol (Gadovist®) for breast MRI
Approved WMORecruiting
Primary Objective: • To evaluate anti-tumor activity of vimseltinib using Response Evaluation Criteria in Solid Tumors (RECIST) v1.1 by blinded independent radiological review (IRR)Secondary Objectives:• To assess anti-tumor activity of vimseltinib…